Rationale: Inositol 1,4,5-trisphosphate receptors (IP 3 Rs) have been implicated in the generation of arrhythmias and cardiac muscle nuclear signaling. However, in the mammalian sinoatrial node (SAN), where the heart beat originates, the expression and functional activity of IP 3 Rs have not been investigated.
F or many years cardiac pacemaker activity was believed to be determined solely by the electric activity of voltage-dependent membrane currents, particularly the hyperpolarization-activated cation current (I f ). 1 However, the discovery that ryanodine, an antagonist of sarcoplasmic reticulum (SR) Ca 2ϩ release channels (ryanodine receptors), slows the heart rate [2] [3] [4] [5] [6] suggested that Ca 2ϩ release from the SR also plays an important role in determining the heart rate. [7] [8] [9] [10] [11] Although ryanodine receptors (RyRs) are the main source of SR Ca 2ϩ release, another class of Ca 2ϩ release channels, inositol 1,4,5-trisphosphate receptors (IP 3 Rs), have been found in cardiac SR membranes. [12] [13] [14] Although the expression level of IP 3 Rs is much lower than RyRs, Ca 2ϩ release from IP 3 Rs modulates the excitation-contraction coupling in both atrial and ventricular myocytes, 15, 16 and several lines of evidence suggest that arrhythmogenic activity in the atria may be associated with increased IP 3 and IP 3 R expression. [17] [18] [19] [20] In addition, new important roles for IP 3 Rs in controlling nuclear transcription factors are emerging. 21, 22 There are three IP 3 R isoforms in mammalian cells: IP 3 R1, IP 3 R2, and IP 3 R3. Among these, IP 3 R2 has the highest affinity for IP 3 14 and is the predominant IP 3 R isoform expressed in ventricular and atrial myocytes. 15 Whereas IP 3 R1 is the dominant isoform present in bovine Purkinje myocytes, 23 little IP 3 R1 has been found in the sinoatrial node (SAN). Thus, both the expression and possible role of IP 3 Rs in the SAN remain unclear. Nevertheless, it is notable that spontaneous pacemaker activity in embryonic stem cellderived cardiomyocytes is strongly dependent on IP 3 Rmediated Ca 2ϩ release. 24, 25 In this study, we have investigated the expression and distribution of IP 3 Rs in the mouse SAN at both mRNA and protein levels and their involvement in the modulation of a heart rate.
Materials and Methods
An expanded Methods section is available in the Online Data Supplement at http://circres.ahajournals.org.
CellsDirect One-Step Quantitative Reverse-Transcription Polymerase Chain Reaction
Samples Ͻ1 mmϫ2 mm were collected from different regions of a mouse heart, including central SAN, peripheral SAN, atrioventricular node (AVN), right atria, and ventricle, respectively, and stored in RNAlater solution (Ambion). Quantitative reversetranscription polymerase chain reaction was performed using the CellsDirect one-step quantitative reverse-transcription polymerase chain reaction kit (Invitrogen, Australia). To achieve complete lysis, samples were vortexed, sonicated, and underwent several thermal cycles (up to 75°C) before treatment with DNase I to degrade genomic DNA. 18s rRNA, the hypoxanthine guanine phosphoribosyl transferase, ␤-actin, and ␤ 2 microglobulin (B2M) mRNA expression were used as reference genes for normalizing data. TaqMan gene expression assays for three Ip 3 r isoforms and the hyperpolarization-activated cyclic nucleotide-gate cation channels (Hcn4) and Ryr2 are listed in the (Online Table I ). The heart samples from different regions of IP 3 R2 knockout (KO) mice and their genetic identical counterpart C57BL/6J mice were also collected and used for a comparison quantitative polymerase chain reaction study. Hela cell RNA was used as a standard reference for minimizing polymerase chain reaction experimental system errors.
Western Blot Analysis
Total protein extracts were prepared from homogenates of the SAN, AVN, atria, and brain tissue by using a mammalian cell lysis kit (Sigma). Protein concentrations were determined using a microBCA protein assay kit (Thermo Scientific). Detection of IP 3 R1 and IP 3 R2 was performed using a rabbit polyclonal antibody to IP 3 R1 (1:1000; ABR) or a rabbit polyclonal antibody against IP 3 R2 (1:500, a gift from Dr Ju Chen's laboratory), as previously described. 19 Immunodetection of ␣-actinin was performed using a mouse monoclonal antibody to sarcomeric ␣-actinin (1:1000; Sigma). After transfer, membranes were treated with Miser antibody extender solution NC (Pierce Biotechnology). Horseradish peroxidase-conjugated antirabbit Ig (1:16 000; Sigma) or antimouse Ig (1:3000; Invitrogen) was used as secondary antibodies, respectively. For detecting IP 3 Rs, the primary and secondary antibodies were also treated with the SignalBoost immunoreactions enhancer kit (Calbiochem).
Immunohistochemistry
Whole SAN preparations as well as isolated single pacemaker cells were labeled with primary antibodies, including IP 3 R1, IP 3 R2, connexin-43 (Cx43), HCN4, RyR2, and SR Ca 2ϩ -ATPase (SERCA2a) using established methods. 26 
Ca 2؉ Measurements
Intact SANs were isolated from the right atria as described previously. 26 The intact SANs were loaded with the membrane-permeable fluorescent Ca 2ϩ indicator, indo-1-AM (10 mol/L), in Tyrode solution containing 100 mol/L Ca 2ϩ for at least 2 hours. The SANs were then washed in Tyrode solution with 1.8 mmol/L Ca 2ϩ containing probenecid (0.5 mmol/L) for Ͼ30 minutes at 35°C. The probenecid, an organic anion carrier inhibitor, was added to reduce leakage of the fluorescent dye. Fluorescent signals were recorded from a restricted region of the SAN area by use of a rectangular field stop. The indo-1 ratio, which is linearly related to [Ca 2ϩ ], was calculated as described previously. 5 In some experiments, confocal microscopy was used to collect Ca 2ϩ images of the intact SANs loaded with fluo-4AM (10 mol/L) or isolated single pacemaker cells loaded with fluo-4AM (2 mol/L) for 15 minutes. Single pacemaker cells were enzymatically isolated from the SAN region of the mouse heart according to the method described previously. 26 
Statistics
Data are expressed as meanϮSEM, with the number of preparations expressed as n. Statistical tests were either Student paired or unpaired t tests, and PϽ0.05 was taken as the level of statistical significance.
Results

Expression and Distribution of IP 3 R Isoforms in the Mouse SAN
We first examined mRNA expression for Ip 3 rs, Hcn4, and Ryr2 across different regions of the mouse heart, including the central SAN, peripheral SAN, AVN, atria, and ventricle. All 3 Ip 3 r mRNA isoforms were expressed in the SAN and other regions of the heart. HCN4 expression was highest in the central SAN and showed progressive reduction in the peripheral SAN, AVN, atria, and ventricle (Online Figure I , A), in agreement with previous studies. 27 The mRNA expression of the 3 types of Ip 3 rs in pacemaker cells was also confirmed in preliminary single cell reverse-transcription polymerase chain reaction experiments using isolated pacemaker cells (data not shown). Western blot analysis was used to examine protein expression in SAN. Protein extracts from brain tissue showed a prominent single band Ͼ250 kDa after incubation with an anti-IP 3 R1 antibody. 14 However, only a weak reaction to the IP 3 R1 antibody was found in cardiac pacemaker tissue, including the SAN and AVN (Figure 1 , top). In contrast to IP 3 R1, a single band migrating Ͼ250 kDa was detected in protein extracts from different regions of the pacemaker tissue, as well as atrial, but not brain tissue, when incubated with the IP 3 R2 antibody (Figure 1 , middle). Immunodetection of ␣-actinin was performed on samples to normalize the protein loading of heart samples (Figure 1, bottom) .
Non-standard Abbreviations and Acronyms
These results demonstrate that mouse pacemaker tissue predominantly expresses type 2 IP 3 Rs, similar to the other regions of the heart. 14 Antibodies against IP 3 Rs showed a single band at the predicted molecular weight for mouse tissue and also demonstrated the specificity of the antibodies (http://www.phosphosite.org/proteinAction.do?idϭ3973 &showAllSitesϭtrue).
To determine the distribution of IP 3 R protein isoforms in the SAN, whole-mount SANs were colabeled with the Cx43 antibody (green) and either IP 3 R1 or IP 3 R2 antibodies (Figure 2 , red). Cx43 labeling was used to distinguish the central SAN from the peripheral SAN. 28 We used confocal image tiling (Zeiss LSM510) to image the entire intact SAN region at high resolution (Figure 2A, B ). We found weak labeling of IP 3 R1 in the central SAN, identified by the absence of Cx43 (Figure 2A ). IP 3 R1 labeling appeared in the peripheral SAN, especially in the interatrial septum, which also showed strong expression of Cx43. At higher resolution, we found that some of the IP 3 R1 labeling in the interatrial septum appeared to be within intracardiac neurons (Online Figure II) . In contrast, the entire SAN, including the central and peripheral SAN and the surrounding atrial tissue, was uniformly labeled with the IP 3 R2 antibody ( Figure 2B , red).
The SAN is a multicellular tissue; therefore, to distinguish the pacemaker cells from other cell types such as endothelial cells and fibroblasts, the HCN4 antibody was used as a marker for pacemaker cells. 27 Positive HCN4 labeling identified the central SAN as shown in Figures 2C and 2D. Very weak IP 3 R1 labeling was found in the HCN4-positive area ( Figure 2C ). In contrast, there was substantial IP 3 R2 labeling in this region and also some colabeling with HCN4-positive cells ( Figure 2D , yellow). To further confirm that pacemaker cells express IP 3 R2 receptors, isolated single pacemaker cells were studied. Figure 3A shows that HCN4 positive pacemaker cells also show positive labeling for IP 3 R2. However, no IP 3 R2 immunoreaction was detected in single pacemaker cells that were isolated from IP 3 R2 KO mice ( Figure 3B ) or whole-mount SAN preparation (Supplemental Figure III) , demonstrating antibody specificity. HCN4 labeling was mainly found along the surface membrane, as might be expected for a sarcolemmal membrane channel protein ( Figure 3A top panel, 3B top panel). However, it is notable that some of the IP 3 R2 labeling also appeared to be located Western blot analysis of IP 3 Rs protein expression in the different regions of mouse pacemaker tissue and brain. Protein extracts (total 15 g protein) from sinoatrial node (SAN), atrioventricular node (AVN), left atria (LA), right atria (RA), and brain (B) from mice were subjected to protein analysis using IP 3 Rs specific antibodies. Top, A single band migrating Ͼ250 kDa is seen clearly only in brain tissue when IP 3 R1 antibody (ABR; 1:1000) was used. Middle, A single band migrating Ͼ250 kDa is seen clearly in all heart samples but not in brain when IP 3 R2 antibody was used (a gift from Dr Ju Chen, 1:500); no other additional bands were seen. Bottom, Antisarcomeric-␣ actinin antibody was used to normalize for protein loading of heart samples. 
Distribution of SR and Ca 2؉ Release Channels in Isolated Pacemaker Cells
To further explore the functional significance of the spatial distribution of IP 3 Rs, we examined colocalization with the SR. SERCA2a is the primary isoform of SERCA expressed in cardiac tissue and is responsible for maintaining the Ca 2ϩ gradient across the cardiac SR membrane. 29 To establish the location of the SR in single pacemaker cells, we first used the anti-SERCA2a antibody as a SR marker. In the majority of isolated single pacemaker cells, SERCA2a staining showed clear sarcomeric labeling patterns ( Figure 4A ). Whereas pacemaker cells have a poorly developed t-tubule system, contractile machinery is organized in sarcomeres. 30 Therefore, such sarcomeric labeling patterns suggest that SR in pacemaker cells might be closely associated with contractile proteins. Similar SR location was also found in toad pacemaker cells. 31 This hypothesis was confirmed by using the Z-line marker ␣-actinin (data not shown). Some of the IP 3 R2s are clearly colocalized with SERCA2a, especially close to the sarcolemma ( Figure 4A, arrow, yellow) . Within the cytoplasm, the distribution of IP 3 R2s seemed quite scattered ( Figure  4A , red) but also followed the regular sarcomeric pattern of SERCA2a labeling. We found increased SERCA2a labeling was present at points of contact between two adjacent pacemaker cells ( Figure 4A, green) . This result is consistent with an early electron microscopy study that showed some SR was coupled to the sarcolemma in rat SAN cells. 30 Subsarcolemmal SR in pacemaker cells can explain why HCN4 and IP 3 R2 appear to be colocalized along the sarcolemma ( Figure 3A bottom panel) , but how does this relate to the distribution of RyR2 (the major Ca 2ϩ release channel in cardiac cells)? Figure 4B shows a single pacemaker cell labeled with the RyR2 antibody (green). RyR2 labeling also shows a repeated sarcomeric pattern representing the distribution of SR in the cell, similar to the SERCA2a labeling pattern described ( Figure 4A ). IP 3 R2s were frequently detected close to the sarcolemma, where some colocalization with RyR2 was also seen ( Figure 4B, yellow) . Again, no IP 3 R1 labeling was apparent, although IP 3 R1 labeling (red) was present in cell debris ( Figure 4C ). These immunohistochemistry data suggested that in pacemaker cells, the RyR is more or less uniformly distributed within SR with IP 3 R2 having a similar distribution, including near subsarcolemmal regions, to reports of other atrial cells. 18 To determine whether the expressed IP 3 R2s in pacemaker cells could function as Ca 2ϩ release channels, we studied Ca 2ϩ sparks, which are localized SR Ca 2ϩ release events. 32 When single pacemaker cells were loaded with the Ca 2ϩ indicator fluo-4, Ca 2ϩ sparks were observed in quiescent pacemaker cells, because such local Ca 2ϩ release events do not require membrane potential depolarization. 33 Ca 2ϩ spark frequency was low under control conditions ( Figure 5A ). The application of a membrane-permeant IP 3 (IP 3 -butyryloxymethyl ester [IP 3 -BM]) increased spark frequency as shown in Figure 5B . The spark frequency increased by 2.86Ϯ1.08-times the control (nϭ7; Pϭ0.01). In addition, the increased Ca 2ϩ spark frequency induced by IP 3 -BM generally appeared close to the cell surface. Figure  5C shows a three-dimensional image that was derived from Figure 5B . The scan line position is indicated in the drawing on the right. There are fewer and less bright sparks in the middle of the cell, as shown in Figure 5D , when the scan line was moved to that position. The localization of Ca 2ϩ sparks induced by the membrane permeable IP 3 -BM supports the immunohistochemistry described and suggests that the active IP 3 Rs sites are close to the sarcolemma. Because of this spatial distribution, Ca 2ϩ release from IP 3 R2s could impact sarcolemmal ionic channels and exchangers.
Ca 2؉ Release From IP 3 Rs Influence Pacemaker Function
To examine whether the pacemaker activity is influenced by IP 3 Rs, the effect of IP 3 -BM on the spontaneous firing of isolated single pacemaker cells was examined. Using the Ca 2ϩ indicator fluo-4, Ca 2ϩ transients associated with spontaneous action potentials were recorded using confocal microscopy ( Figure 6A ). The spontaneous firing rate and amplitude of Ca 2ϩ transients were determined by using XT scans in which laser scans along a fixed line were plotted against time ( Figure 6B and 6C) . Ca 2ϩ sparks were easily observed only when scan lines were located close to the surface membrane. When IP 3 -BM was added to the bath solution, we found that the firing rate was increased by 12.6%Ϯ5% (nϭ4; PϽ0.04) and the Ca 2ϩ transient amplitude was increased by 15.3%Ϯ6% (PϽ0.05). The number of Ca 2ϩ sparks also appeared to increase, especially during the diastolic phase of Ca 2ϩ transients ( Figure  6C, arrows) . Similar firing rate changes were also observed in isolated cells that were not loaded with the fluorescent Ca 2ϩ indicator (nϭ6; PϽ0.04). Endothelin-1 (ET-1) has been shown to increase endogenous IP 3 production through its activation of ET A receptors that are coupled to the phospholipase C-IP 3 signaling pathway. 34 Using intact SAN loaded with the ratiometric Ca 2ϩ indicator, indo-1, we recorded pacemaker activity influenced by modulation of IP 3 Rs by ET-1 and phospholipase C-IP 3 signaling pathway. Although the pacemaker firing rate was significantly reduced when indo-1 was loaded into pacemaker cells, 5 this approach has the added benefit of allowing diastolic Ca 2ϩ to be measured. In the presence of ET-1 (100 nmol/L), the resting [Ca 2ϩ ] i , the Ca 2ϩ transient amplitude and firing rate all increased as shown in Figure 7A . The resting Ca 2ϩ was increased by 36%Ϯ13% (nϭ5; PϽ0.05), the Ca 2ϩ transient amplitude was increased by 10%Ϯ2% (PϽ0.05), and the firing rate was increased by 20Ϯ8% (PϽ0.05). IP 3 -BM (10 mol/L) applied to intact SAN produced similar but less pronounced effects ( Figure 7B ), possibly because of its slow penetration into a multicellular preparation. Figure 7C shows a summary of these data.
To further evaluate the influence of IP 3 Rs on pacemaker activity, we studied intact SAN preparations from IP 3 R2 KO and their wild-type (WT) counterparts. 19 The relative mRNA expression of Ip 3 r, Hcn4, and Ryr2 were analyzed in these mice and the only significant change was the absence of Ip 3 r2 in the KO (Supplemental Figure IB) . Thus, the other IP 3 R subtypes do not compensate for the loss of IP 3 R2.
We found that the average firing rate (at 35°C, before loading with Ca 2ϩ indicator) was 206Ϯ3 per minute in SANs from IP 3 R2 KO mice, which was approximately 12% lower than the 235Ϯ11 per minute recorded in WT mice (nϭ9; PϽ0.001). Isoproterenol (ISO) 100 (nmol/L) accelerated the firing rate of SANs from both WT and IP 3 R2 KO mice, as shown in Figure 8B . However, the response to IP 3 R agonists was different between WT and IP 3 R2 KO. In the WT SAN, ET-1 increased the pacemaker firing rate and could also induce irregular firing ( Figure  8C ). However, no significant firing rate changes were observed in IP 3 R KO mice when ET-1 was applied ( Figure  8C , left; 185Ϯ23 per minute control vs 180Ϯ26 per minute ET-1; nϭ7; PϾ0.05). In some experiments ( Figure 8C ), ET-1 caused a decrease in the amplitude of the Ca 2ϩ transient (F/F 0 ) in KO mice. However, this change was not statistically significant (1.64Ϯ0.34 WT vs 1.40Ϯ0.33 KO; nϭ7; PϾ0.05).
2-APB is a synthetic membrane-permeable antagonist of IP 3 R and is widely used to investigate the role of IP 3 R, although it can have a variety of other effects. [35] [36] [37] Because higher concentrations of 2-APB (Ͼ30 mol/L) suppressed atrial EC coupling, 18 a lower concentration of 2APB (Ͻ5 mol/L) has commonly been used to investigate the involvement of IP 3 R in atrial arrhythmias. 18, 19 It was found that in isolated atrial cells, 2-APB inhibits Ca 2ϩ release from IP 3 Rs. 19, 38 We found that at 5 mol/L, 2-APB had a minimal effect on the pacemaker action potential but slowed the firing rate (data not shown). In the presence of 5 mol/L 2-APB ( Figure 8D ), the firing rate of intact SANs from WT was reduced, on average, by 24%Ϯ13% (PϽ0.05). In contrast, the firing rate of SANs in KO mice showed no significant change (185Ϯ23 per minute control vs 174Ϯ17 per minute 2-APB; nϭ7; PϾ0.05). The absence of effects of the IP 3 R agonist and antagonist in IP 3 R2 KO mice is strong evidence that IP 3 R2 can modulate heart rate.
Discussion
Identification of the IP 3 R Isoforms and IP 3 R Ca 2؉ Release Sites in Pacemaker Cells
In mammals, the three IP 3 R isoforms are encoded by three different genes. IP 3 R1 is strongly expressed in Purkinje myocytes 23 and in cardiomyocytes derived from embry- onic stem cells, where it is involved in the generation of pacemaker activity. 24, 25 In the present study, we were able to detect mRNA for all 3 Ip 3 r isoforms in the SAN, consistent with previous studies showing that hearts express mRNA for all 3 Ip 3 r isoforms. 15, 16 Ip 3 r3 showed the lowest expression level in SAN, but we could not explore the protein distribution of this isoform because of a lack of suitable primary antibodies. Nevertheless, the Western blot analysis and imaging data showed a preferential expression of IP 3 R2 over IP 3 R1 in the SAN and isolated pacemaker cells.
The immunohistochemistry data show a generally similar distribution of IP 3 R2s to SR markers (RyR2 and SERCA2a), except that there is some preferential distribution of IP 3 R2 close to the sarcolemma (Figures 3, 4 ). In addition, active Ca 2ϩ release sites revealed by Ca 2ϩ sparks induced by IP 3 are also close to the surface membrane ( Figure 5 ), where many signaling proteins, including G-proteins, phospholipase C, and TRP channels, are located. 26 This is in accord with the existence of subsarcolemmal SR as observed in electron microscopy 30 and as detected using the SERCA2a antibody ( Figure 4 ). In atrial cells, increased Ca 2ϩ release activity by IP 3 -BM was also identified close to the membrane (Ͻ1.5 m from the sarcolemma). 14 A similar localization of Ca 2ϩ sparks was also found in toad pacemaker cells. 31 The distribution and localization of IP 3 R2s in pacemaker cells emphasize that local Ca 2ϩ released from IP 3 R2s may play a significant role in the modulation of Ca 2ϩ -dependent pacemaker activity. Although the Ca 2ϩ spark rate was stimulated by IP 3 (Figures 5, 6) , it is unclear whether these Ca 2ϩ sparks were attributable to an initial Ca 2ϩ release from IP 3 R2, which then triggered additional Ca 2ϩ release from neighboring RyR2s, or were directly attributable to IP 3 R2 activity, especially during the pacemaker firing ( Figure 6 ). However, the colocalization of RyR2 and IP 3 R2 near the sarcolemmal membrane ( Figure 4B) would permit crosstalk between the RyRs and IP 3 Rs in this region, favoring the former possibility. 38 
Involvement of IP 3 R Ca 2؉ Signaling in the Modulation of Pacemaker Activity
In the present study, we provide new evidence that pacemaker cells express IP 3 R2 in addition to RyR2. This suggests that pacemaker activity should be sensitive to modulation through G-protein/phospholipase C/IP 3 signaling pathways under physiological or pathological conditions. We suggest that IP 3 production increases the frequency of Ca 2ϩ sparks close to the membrane (Figures 5,  6) , which, in turn, activate Na/Ca exchange current (or other Ca 2ϩ -dependent currents), increasing the rate of depolarization and heart rate. The involvement of SR Ca 2ϩ release and NCX current is well-established, 39 but Ca 2ϩ release from RyR2 should predominate because there is approximately 50-times higher levels of expression of Ryr compared to Ip 3 rs. 40 However, the localization of IP 3 R2 close to the surface membrane, where IP 3 is produced and where the Na/Ca exchangers are located, might offset the relative paucity of the IP 3 Rs and thereby allow them to contribute more effectively to changes in the firing rate. In the current study, we took advantage of transgenic mice in which Ip 3 R2 was deleted whereas the expression of Ryr2, Hcn4, Ip 3 R1, and Ip 3 R3 was essentially unaltered (Supplemental Data). The IP 3 R2 immunoreactivity was also absent in single pacemaker cells isolated from IP 3 R2 KO mice ( Figure 3B ). From these studies, we estimate that Ca 2ϩ release from IP 3 Rs to the normal heart rate could contribute up to 12% of the basal firing rate (the spontaneous firing rate of isolated SANs from WT vs IP 3 R2 KO mice). Although modest, such a contribution is also supported by the effects of the IP 3 R agonist ET-1 and the membrane permeable IP 3 analog. Confidence of this interpretation is increased by our observation that the modulation of pacemaker firing by IP 3 R agonists and antagonists was abolished ( Figure 8C , D) in IP 3 R2 KO mice.
Given that the change of the firing rate induced by IP 3 is small, one would not expect IP 3 to have large effects on the heart rate in intact animals because any changes would be opposed by the autonomic nervous system. However, our results suggest that IP 3 R-mediated Ca 2ϩ signaling could provide an additional pacemaker mechanism in the adult heart analogous to that which operates in embryonic stem cell-derived cardiomyocytes. 25 We also previously reported that in cane toad pacemaker cells, ATP modulates intracellular Ca 2ϩ and firing rate through a P2Y1 purinoceptor and phospholipase C signaling pathway. 41 The fact that IP 3 increases the excitability of pacemaker cells also supports previous findings that IP 3 can lead to arrhythmias under some circumstances. 18, 19 Furthermore, under pathological conditions, the contribution of IP 3 R may increase and we recently reported a substantial increase in IP 3 generation in atrial tissue from valvular heart disease patients, as well as in the atria of mice with dilated cardiomyopathy. 42 In connection with this, increased expression of IP 3 R2 has been reported by others in heart failure or valve disease also. 43, 44 Therefore, the effect of IP 3 on pacemaker electric activity could become more significant under pathological conditions. In addition, there is evidence showing that IP 3 -mediated Ca 2ϩ release promotes myocardial hypertrophy initiated by G-proteincoupled receptors via the Ca 2ϩ -sensitive calcineurin signaling pathway that activates the nuclear factor of activated T-cell transcription factors (NFATc1). 21, 22 A previous study showed that this signaling pathway also modulates HCN gene expression. 45 Therefore, IP 3 R may also influence pacemaker activity indirectly by activation of Ca 2ϩ -sensitive signaling pathways and altering the expression of primary pacemaker ion channels. 
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